2:11 AM GMT, Oct 22, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact firstname.lastname@example.org.
Myriad planning spinout
Myriad (NASDAQ:MYGN) said it will spin off its research and drug
Read the full 112 word article